These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1179037)

  • 1. Effect of oral antidiabetic drugs on lipase activity in vitro.
    Holmes JH; Sapeika N; Zwarenstein H
    Res Commun Chem Pathol Pharmacol; 1975 Aug; 11(4):667-70. PubMed ID: 1179037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of anti-obesity drugs on lipase activity in vitro.
    Holmes JH; Sapeika N; Zwarenstein H
    Res Commun Chem Pathol Pharmacol; 1975 Apr; 10(4):739-42. PubMed ID: 1171512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mode of action of oral hypoglycaemic agents. II. Sulphonylureas & biguanides in rats.
    Augusti KT; Kurup PA
    Indian J Biochem; 1969 Mar; 6(1):36-9. PubMed ID: 4332123
    [No Abstract]   [Full Text] [Related]  

  • 4. Sulphonylureas and biguanides do not affect insulin binding in H35 hepatoma cells.
    De Vries CP; van der Veen EA
    Diabetes Res; 1986 Jul; 3(6):307-10. PubMed ID: 3757414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of biguanides and sulfonylureas on insulin receptors in cultured cells.
    Goldfine ID; Iwamoto Y; Pezzino V; Trischitta V; Purrello F; Vigneri R
    Diabetes Care; 1984; 7 Suppl 1():54-8. PubMed ID: 6734405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative activity of some biguanides, sulfonylureas and their combinations on blood sugar and lactic acid in the guinea pig. II].
    Bramanti G; Bianchini P; De Fina V; Dell'Omodarme G
    Boll Chim Farm; 1971 Apr; 110(4):226-36. PubMed ID: 5111348
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mode of action of oral antidiabetic drugs].
    Frey H
    Tidsskr Nor Laegeforen; 1973 Aug; 93(23):1591-5. PubMed ID: 4588814
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of anti-inflammatory drugs on lipase in vitro.
    Zwarenstein H; Sapeika N; Holmes JH
    Res Commun Chem Pathol Pharmacol; 1976 Mar; 13(3):563-5. PubMed ID: 935643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral hypoglycemic agents: the pharmacological basis of their clinical use.
    Davidoff F
    R I Med J; 1973 Oct; 56(10):409-14. PubMed ID: 4518221
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatic effects of oral hypoglycemic drugs.
    Davidoff F
    Fed Proc; 1977 Dec; 36(13):2724-7. PubMed ID: 336410
    [No Abstract]   [Full Text] [Related]  

  • 11. Biguanides. Mode of action and role in the up-to-date treatment of diabetes mellitus.
    Fövényi J
    Ther Hung; 1971; 19(2):43-8. PubMed ID: 5172874
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinically important effects of oral antidiabetic drug interactions].
    Drzewoski J; Kopff B
    Pol Merkur Lekarski; 2000 Sep; 9(51):605-7. PubMed ID: 11126985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical pharmacology and rational therapeutic use of antidiabetic drugs].
    Giraudo JR
    Rev Fac Cien Med Univ Nac Cordoba; 1979; 37(1-4):28-33. PubMed ID: 556116
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment.
    Harrigan RA; Nathan MS; Beattie P
    Ann Emerg Med; 2001 Jul; 38(1):68-78. PubMed ID: 11423816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Extrapancreatic effects of sulfonylurea compounds. IV. Increase of the effect of insulin due to tolbutamide, glibornuride, and glibenclamide in vitro].
    Beyer J; Gather W; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2179. PubMed ID: 4198966
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical pharmacology of oral hypoglycemic drugs].
    Tatoń J
    Pol Tyg Lek; 1968 Sep; 23(34):1289-92. PubMed ID: 5722532
    [No Abstract]   [Full Text] [Related]  

  • 17. New oral antidiabetic drugs. Synthesis and structure-activity relationships.
    Francia E; Marin A; Verdejo F; Sanchez MS; Morell J
    Boll Chim Farm; 1975 Jul; 114(7):379-92. PubMed ID: 1164447
    [No Abstract]   [Full Text] [Related]  

  • 18. [The pharmacological blockade of protein glycosylation in diabetes mellitus using sulfonylurea derivatives and biguanides].
    Lebedeva EA
    Eksp Klin Farmakol; 1996; 59(5):40-2. PubMed ID: 9026209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral hypoglycemic agents.
    N Engl J Med; 1977 Aug; 297(7):394-6. PubMed ID: 406566
    [No Abstract]   [Full Text] [Related]  

  • 20. Antidiabetic drugs after the University Group Diabetes Program (UGDP).
    Karam JH; Matin SB; Forsham PH
    Annu Rev Pharmacol; 1975; 15():351-66. PubMed ID: 1096790
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.